Yingzhou Tian

No ORCID on file · 4 papers in corpus · active 2019-2026

Study types

  • article 2
  • other 1
  • preprint 1

Condition tags

  • endometriosis 3
  • adenomyosis 2
  • dysmenorrhea 1
article 2026
·doi:10.3389/fmed.2026.1776698

Objective: To systematically evaluate the efficacy and safety of blood-invigorating and stasis-resolving Chinese herbal medicines (BISMs) when combined with conventional clinical therapy for endometriosis, and to provide evidence-based guid…

article 2026
Tissue & cell ·doi:10.1016/j.tice.2026.103581

Adenomyosis (ADM) is a benign condition associated with various gynecological disorders. However, effective treatment options are limited, highlighting the urgent need for novel therapeutic targets. This study identified abnormal activation…

other 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1691279

Endometriosis (EMs) is an estrogen-dependent chronic inflammatory disease. While apoptosis resistance (evidenced by Bcl-2 upregulation and Bax/caspase-3 downregulation) remains a hallmark of EMs, recent studies reveal a paradoxical coexiste…

preprint 2019
·doi:10.21203/rs.2.9951/v1

Abstract Endometriosis and adenomyosis are two of the most common causes of secondary dysmenorrhea and often lead to a deterioration in the quality of life. Traditional Chinese medicine and acupuncture are widely used in the treatment of me…